• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个对甲状腺激素普遍抵抗的家族中,c-erbAβ甲状腺激素受体密码子315处的精氨酸突变为组氨酸,导致该受体具有显著的3,5,3'-三碘甲状腺原氨酸结合活性。

An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.

作者信息

Cugini C D, Leidy J W, Chertow B S, Bérard J, Bradley W E, Menke J B, Hao E H, Usala S J

机构信息

Medical Service, Huntington Veterans Administration Medical Center, West Virginia 25704.

出版信息

J Clin Endocrinol Metab. 1992 May;74(5):1164-70. doi: 10.1210/jcem.74.5.1314846.

DOI:10.1210/jcem.74.5.1314846
PMID:1314846
Abstract

Generalized resistance to thyroid hormones results from diverse mutations in the T3-binding domain of the c-erbA beta thyroid hormone receptor, and different kindreds have variable phenotypes. However, the T3-binding affinities of these mutant receptors studied in vitro have all been severely reduced compared to wild type. We report here a new kindred, CL, with a mutation further upstream than previously reported, a guanine to adenine base substitution at nucleotide 1244 in codon 315 changing an arginine to histidine. This base substitution was the only one found in codons 90-456 of genomic sequence and was formally shown to be a mutation by screening 51 random individuals. The kindred CL receptor complementary DNA was recreated, and the mutant receptor synthesized with rabbit reticulocyte lysate had a T3-binding affinity of 2.4 +/- 0.9 x 10(10) M-1 compared to the wild-type human placental receptor affinity of 5.2 +/- 1.6 x 10(10) M-1. Affected members of this kindred appeared clinically to have a relatively mild degree of resistance with mean total thyroxine of only 192 +/- 24 nmol/L and inappropriately normal TSH levels. Kindred CL is an example of mild generalized resistance to thyroid hormones correlated with a mutation in the beta-receptor that resulted in only a modest deficiency in T3-binding activity.

摘要

全身性甲状腺激素抵抗源于甲状腺激素受体c-erbAβ的T3结合结构域中的多种突变,不同家族具有不同的表型。然而,与野生型相比,这些在体外研究的突变受体的T3结合亲和力均显著降低。我们在此报告一个新家族CL,其突变位置比先前报道的更靠上游,密码子315中第1244位核苷酸的鸟嘌呤到腺嘌呤碱基替换,导致精氨酸变为组氨酸。该碱基替换是基因组序列密码子90 - 456中唯一发现的,通过筛查51名随机个体正式证明这是一种突变。重新构建了家族CL受体互补DNA,用兔网织红细胞裂解物合成的突变受体的T3结合亲和力为2.4±0.9×10(10)M-1,而野生型人胎盘受体亲和力为5.2±1.6×10(10)M-1。该家族的受累成员临床症状显示出相对轻度的抵抗,平均总甲状腺素仅为192±24 nmol/L,促甲状腺激素水平却异常正常。家族CL是轻度全身性甲状腺激素抵抗的一个例子,与β受体突变相关,该突变仅导致T3结合活性适度缺乏。

相似文献

1
An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.在一个对甲状腺激素普遍抵抗的家族中,c-erbAβ甲状腺激素受体密码子315处的精氨酸突变为组氨酸,导致该受体具有显著的3,5,3'-三碘甲状腺原氨酸结合活性。
J Clin Endocrinol Metab. 1992 May;74(5):1164-70. doi: 10.1210/jcem.74.5.1314846.
2
A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.c-erbAβ甲状腺激素受体的3,5,3'-三碘甲状腺原氨酸结合域中的一个新的点突变与全身性甲状腺激素抵抗紧密相关。
J Clin Endocrinol Metab. 1991 Jan;72(1):32-8. doi: 10.1210/jcem-72-1-32.
3
A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.一个患有全身性甲状腺激素抵抗的家族中C-erbAβ甲状腺激素受体的碱基突变。另外两个家族中的分子异质性。
J Clin Invest. 1990 Jan;85(1):93-100. doi: 10.1172/JCI114438.
4
A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.一名全身性甲状腺激素抵抗患者的c-erbAβ甲状腺激素受体基因纯合缺失:突变受体的分离与鉴定
Mol Endocrinol. 1991 Mar;5(3):327-35. doi: 10.1210/mend-5-3-327.
5
An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.C-erbAβ基因第311密码子处的精氨酸突变为组氨酸,导致一种突变的甲状腺激素受体,该受体不介导显性负性表型。
J Clin Invest. 1993 Feb;91(2):538-46. doi: 10.1172/JCI116233.
6
A point mutation in the 3,5,3'-triiodothyronine-binding domain of thyroid hormone receptor-beta associated with a family with generalized resistance to thyroid hormone.甲状腺激素受体β的3,5,3'-三碘甲状腺原氨酸结合域中的一个点突变,与一个全身性甲状腺激素抵抗家族相关。
J Clin Endocrinol Metab. 1992 Jul;75(1):213-7. doi: 10.1210/jcem.75.1.1619012.
7
Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor.全身性甲状腺激素抵抗:c-erb Aβ甲状腺激素受体第315密码子精氨酸至胱氨酸突变的鉴定
J Endocrinol Invest. 1992 Sep;15(8):573-9. doi: 10.1007/BF03344927.
8
Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.在散发性家族性全身性甲状腺激素抵抗患者中c-erbAβ基因七个新突变的特征分析。配体结合域两个“热点”区域的证据。
J Clin Invest. 1991 Dec;88(6):2123-30. doi: 10.1172/JCI115542.
9
Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.突变型β1甲状腺激素受体的不同二聚化特性与不同的显性负性活性相关。
Mol Endocrinol. 1994 Jul;8(7):841-51. doi: 10.1210/mend.8.7.7984146.
10
Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3'-triiodothyronine receptor-beta.垂体对甲状腺激素抵抗与人类3,5,3'-三碘甲状腺原氨酸受体β激素结合域的碱基突变有关。
J Clin Endocrinol Metab. 1993 May;76(5):1254-8. doi: 10.1210/jcem.76.5.8496318.

引用本文的文献

1
One Novel and Two Recurrent THRB Mutations Associated with Resistance to Thyroid Hormone: Structure-based Computational Mutation Prediction.一个与甲状腺激素抵抗相关的新型及两个复发性THRB突变:基于结构的计算突变预测
Clin Pediatr Endocrinol. 2010 Oct;19(4):91-9. doi: 10.1297/cpe.19.91. Epub 2010 Dec 29.
2
Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.一名患有甲状腺激素受体新突变儿童的内分泌和神经心理学评估:对12个月三碘甲状腺乙酸(TRIAC)治疗的反应。
J Endocrinol Invest. 2005 Jul-Aug;28(7):657-62. doi: 10.1007/BF03347267.
3
Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.
在对15个家庭的分析中发现,甲状腺激素受体β基因富含胞嘧啶-鸟嘌呤的区域出现了与甲状腺激素普遍抵抗相关的不相关家庭中的相同突变。
J Clin Invest. 1993 Jun;91(6):2408-15. doi: 10.1172/JCI116474.
4
An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.C-erbAβ基因第311密码子处的精氨酸突变为组氨酸,导致一种突变的甲状腺激素受体,该受体不介导显性负性表型。
J Clin Invest. 1993 Feb;91(2):538-46. doi: 10.1172/JCI116233.
5
Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.位于甲状腺激素受体(TR)β基因的三碘甲状腺原氨酸(T3)结合域中的CpG二核苷酸突变似乎没有自然突变,可能无法被检测到,因为它们不太可能产生甲状腺激素抵抗的临床表型。
J Clin Invest. 1994 Aug;94(2):607-15. doi: 10.1172/JCI117376.
6
Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.对29个患有全身性和垂体性甲状腺激素抵抗的家族进行的基因分析。甲状腺激素受体β基因中13个新突变的鉴定。
J Clin Invest. 1994 Aug;94(2):506-15. doi: 10.1172/JCI117362.
7
Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K.甲状腺激素抵抗中甲状腺激素受体β基因突变的命名法。甲状腺激素抵抗首次研讨会,1993年7月10 - 11日,英国剑桥
J Endocrinol Invest. 1994 Apr;17(4):283-7. doi: 10.1007/BF03348977.
8
The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.甲状腺激素受体的tau 4激活结构域是释放转录沉默所需的一种假定共抑制因子所必需的。
Mol Cell Biol. 1995 Jan;15(1):76-86. doi: 10.1128/MCB.15.1.76.
9
Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor.全身性甲状腺激素抵抗:c-erb Aβ甲状腺激素受体第315密码子精氨酸至胱氨酸突变的鉴定
J Endocrinol Invest. 1992 Sep;15(8):573-9. doi: 10.1007/BF03344927.